The preliminary results of perfluoroctylbromide (PFOB) emulsion when used an an intravenous contrast agent for hepatosplenic CT imaging in humans are reported. Ten patients were examined using dosages ranging from 1 to 2 g/kg. There was good clinical and biochemical tolerance. Diagnostic dose for liver enhancement seems to be at least 2 g/kg, whereas 1 g/kg was sufficient for splenic enhancement.
|Original language||English (US)|
|Issue number||SUPPL. 1|
|State||Published - Jan 1 1988|
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging